Nintedanib for systemic sclerosis-associated interstitial lung disease. Reply
File(s) Nintedanib-for-Systemic-Sclerosis-Associated-reply.pdf (72.36 KB)
Published version
Author(s)
Distler, Oliver
Gahlemann, Martina
Maher, Toby M
Type
Journal Article
Date Issued
2019-10-17
Date Acceptance
2019-10-01
Citation
New England Journal of Medicine, 2019, 381 (16), pp.1596-1597
ISSN
0028-4793
Publisher
Massachusetts Medical Society
Start Page
1596
End Page
1597
Journal / Book Title
New England Journal of Medicine
Volume
381
Issue
16
Copyright Statement
© 2019 Massachusetts Medical Society. All rights reserved.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/31618556
PII: 10.1056/NEJMc1910735#sa3
Subjects
General & Internal Medicine
11 Medical and Health Sciences
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2019-10-17
